ALLTEST Saliva Panels Drug & Alcohol Test Kits

Wholesale Saliva Drug Testing Kits DSD-8*5 Series For Rapid Employment Drug Screening. The ALLTEST Oral Fluid Saliva Drug Test Kit range provides a fast and practical solution for professional drug and alcohol screening across workplace, transport, and safety-critical environments. Developed for employers, fleet operators, taxi and private hire companies, logistics providers, and occupational health professionals, these kits enable rapid onsite screening where speed, reliability, and operational efficiency are essential. Manufactured in accordance with internationally recognised ISO 13485 and ISO 9001 quality standards, the ALLTEST saliva collection device is designed for straightforward professional use. Its integrated collection and testing system combines controlled sample acquisition with rapid analytical performance, supporting compliant workplace drug and alcohol testing programmes. The ALLTEST DSD-8*5 Series is a preliminary, non-evidential screening device intended for use as the first stage of workplace health, safety, and compliance testing procedures. The test is designed to indicate the potential presence of drugs in oral fluid, helping organisations identify which samples require confirmatory laboratory analysis as part of a two-step testing process. All non-negative results generated by ALLTEST drug test kits must be treated as presumptive screening results only and are not suitable as evidential findings. Before any disciplinary, contractual, regulatory, or financial action is taken, all non-negative results should be confirmed through accredited laboratory analysis provided by an accredited and authorised laboratory confirmation service from UKDrugTesting. The DSD-85 range is available in a comprehensive selection of 7-panel to 17-panel configurations, including combined drug and alcohol screening options. While the device is slightly larger and less portable than the DSD-87 and DSD-83 series, it offers significantly expanded drug detection capabilities through broader panel combinations. Selected configurations also support testing for emerging cannabinoid compounds, including THC-P, Delta-9 THC, and Delta-8 THC, providing direct cannabinoid detection. In contrast, many conventional oral fluid tests are limited to detecting only standard cannabis markers or metabolites, making the DSD-85 series particularly well suited for organisations seeking enhanced cannabis screening coverage and wider substance detection profiles.